Tissue Study on the Chronic Active Humoral Rejection (cAMR) Population of Kidney Transplantation

Recruiting now

Conditions studied: Kidney Transplant

In brief

The study is tissue-based, retrospective and prospective, single-centre, non-sponsored. Primary objective: To examine patient and organ survival and eGFR variation in kidney transplant patients diagnosed histologically with cAMR.

Key facts

Study ID

NCT06794970

Run by

IRCCS Azienda Ospedaliero-Universitaria di Bologna

People needed

50

Starts

2023-05-01

Expected to finish

2028-11-01

Last updated by the study team

2025-01-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥18 years
• Kidney transplant recipients
• eGFR>15 ml/min/1.73 sq m at the time of diagnosis of cAMR
• cAMR diagnosis defined on the basis of the 2018 Banff Classification (17), made after 1/1/2018.
• Obtaining Informed Consent to Participation.

You may not qualify if…

• Combined transplant patients (heart-kidney, liver-kidney or kidney-pancreas)
• Histological evidence of concomitant disease (e.g. recurrence of original nephropathy or diagnosis of 'de novo' nephropathy, acute cellular rejection, polyomavirus BK nephropathy, other)

Where it is running

• IRCCS Sant'Orsola University Hospital - Nephrology, Dialysis and Transplant Unit — Bologna, BO, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.